Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Xu Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8787-1102; OpenAlex author ID A5100331732. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 4

  1. HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription. Co-author DOI 10.1007/s12094-022-03048-7↗
  2. SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells. First author DOI 10.1111/cpr.12799↗
  3. DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway. Co-author DOI 10.3892/ol.2020.12009↗
  4. Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA. Co-author DOI 10.1016/j.vaccine.2013.07.055↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunbo Zhao · 1 shared paper, 2023 · strength 0.24
  2. Qian Zhang · 1 shared paper, 2023 · strength 0.24
  3. Zhan Jian · 1 shared paper, 2023 · strength 0.24
  4. Lifu Wang · 2 shared papers, 2020 · strength 0.21
  5. Tong Li · 2 shared papers, 2020 · strength 0.21
  6. Xinyang Huang · 1 shared paper, 2020 · strength 0.11
  7. Qi Wang · 1 shared paper, 2020 · strength 0.11
  8. Yi Zang · 1 shared paper, 2020 · strength 0.10
  9. Qi Wang · 1 shared paper, 2020 · strength 0.10
  10. Hongyu Li · 1 shared paper, 2013 · strength 0.04
  11. Jiajun Zhao · 1 shared paper, 2013 · strength 0.04
  12. Chen Jiang · 1 shared paper, 2013 · strength 0.04
  13. Xiaozhong Guo · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.